OBJECTIVE: Our purpose was to determine the effects of magnesium sulfate therapy on preeclamptic women and their fetuses with regard to the hormones and ions involved with calcium homeostasis, including 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone, and calcium. STUDY DESIGN: The study group comprised 15 preeclamptic women at term treated with magnesium sulfate during labor. Controls were seven normal women in term labor. The hormones and ions were measured in maternal blood obtained at the onset of labor and at delivery and in umbilical venous (fetal) blood. RESULTS: Baseline maternal levels of 25-hydroxyvitamin D and parathyroid hormone were lower in preeclamptics than in controls. Magnesium infusion led to significant elevations in magnesium, 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, and parathyroid hormone levels and lowered calcium concentrations. Fetuses of treated subjects demonstrated reductions in serum total and ionized calcium and elevations of 1,25-dihydroxyvitamin D and parathyroid hormone. CONCLUSION: Magnesium sulfate infusion causes reductions in both maternal and fetal calcium levels. Both mother and fetus respond with increased 1,25-dihydroxyvitamin D and parathyroid hormone levels, which may prevent more severe maternal, fetal, and neonatal hypocalcemia.
OBJECTIVE: Our purpose was to determine the effects of magnesium sulfate therapy on preeclamptic women and their fetuses with regard to the hormones and ions involved with calcium homeostasis, including 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone, and calcium. STUDY DESIGN: The study group comprised 15 preeclamptic women at term treated with magnesium sulfate during labor. Controls were seven normal women in term labor. The hormones and ions were measured in maternal blood obtained at the onset of labor and at delivery and in umbilical venous (fetal) blood. RESULTS: Baseline maternal levels of 25-hydroxyvitamin D and parathyroid hormone were lower in preeclamptics than in controls. Magnesium infusion led to significant elevations in magnesium, 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D, and parathyroid hormone levels and lowered calcium concentrations. Fetuses of treated subjects demonstrated reductions in serum total and ionizedcalcium and elevations of 1,25-dihydroxyvitamin D and parathyroid hormone. CONCLUSION:Magnesium sulfate infusion causes reductions in both maternal and fetal calcium levels. Both mother and fetus respond with increased 1,25-dihydroxyvitamin D and parathyroid hormone levels, which may prevent more severe maternal, fetal, and neonatal hypocalcemia.
Authors: Tonya S Orchard; Joseph C Larson; Nora Alghothani; Sharon Bout-Tabaku; Jane A Cauley; Zhao Chen; Andrea Z LaCroix; Jean Wactawski-Wende; Rebecca D Jackson Journal: Am J Clin Nutr Date: 2014-02-05 Impact factor: 7.045
Authors: Arthur M Baker; Sina Haeri; Carlos A Camargo; Janice A Espinola; Alison M Stuebe Journal: J Clin Endocrinol Metab Date: 2010-08-18 Impact factor: 5.958
Authors: Lisa M Bodnar; Janet M Catov; Hyagriv N Simhan; Michael F Holick; Robert W Powers; James M Roberts Journal: J Clin Endocrinol Metab Date: 2007-05-29 Impact factor: 5.958